Furthermore, it has been documented that shikonin can activate p53 in response to DNA damage, downregulating Bcl-2 and upregulating Bax, and lowering the expression of cdk4, which causes apoptosis in human malignant melanoma A375-S2 cells [55]. This evidence concerns the gene CDK4 and melanoma.